Marina CAVAZZANA, MD, PhD

Trials

Studies that name Marina CAVAZZANA, MD, PhD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:19 UTC. Open this list on ClinicalTrials.gov

• N/A
  NCT07752043 · Standard of Care Comparative Arm of Phase 1/2 Gene Therapy Trial DREPAMIR" in Severe Sickle Cell Disease Patients

  Assistance Publique - Hôpitaux de Paris · not yet recruiting · Sickle Cell Disease (SCD), Vaso-occlusive Events · study director
• Ph1/Ph2
  NCT03593187 · A Study Evaluating the Safety of Cal-1 (LVsh5/C46) Drug Product in HIV-1 Infected Patient With High Risk Lymphoma

  Assistance Publique - Hôpitaux de Paris · completed · HIV-1 Infection · study chair
• Ph3
  NCT02813850 · Oxygen Therapy and Pregnancy in Sickle Cell Disease

  Assistance Publique - Hôpitaux de Paris · completed · Sickle Cell Disease · principal investigator
• Ph2
  NCT02737384 · Hematopoietic Stem Cells Transplantation in Children With Combined Immunodeficiency (CID)

  Assistance Publique - Hôpitaux de Paris · terminated · Combined Immunodeficiencies · study chair
• Ph1/Ph2
  NCT02678533 · Mobilization and Collection of Peripheral Blood Stem Cells in Patients With Fanconi Anemia Using G-CSF and Plerixafor

  Assistance Publique - Hôpitaux de Paris · completed · Fanconi Anemia · study director

Grants

NIH projects from RePORTER, fetched 2026-11-12 12:19 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.